1. Home
  2. PCRX vs ESQ Comparison

PCRX vs ESQ Comparison

Compare PCRX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ESQ
  • Stock Information
  • Founded
  • PCRX 2006
  • ESQ 2006
  • Country
  • PCRX United States
  • ESQ United States
  • Employees
  • PCRX N/A
  • ESQ N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ESQ Commercial Banks
  • Sector
  • PCRX Health Care
  • ESQ Finance
  • Exchange
  • PCRX Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • PCRX 1.2B
  • ESQ 638.2M
  • IPO Year
  • PCRX 2011
  • ESQ 2017
  • Fundamental
  • Price
  • PCRX $26.09
  • ESQ $87.62
  • Analyst Decision
  • PCRX Buy
  • ESQ Hold
  • Analyst Count
  • PCRX 10
  • ESQ 3
  • Target Price
  • PCRX $29.30
  • ESQ $88.00
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • ESQ 113.9K
  • Earning Date
  • PCRX 02-27-2025
  • ESQ 01-23-2025
  • Dividend Yield
  • PCRX N/A
  • ESQ 0.81%
  • EPS Growth
  • PCRX N/A
  • ESQ 4.68
  • EPS
  • PCRX N/A
  • ESQ 5.14
  • Revenue
  • PCRX $694,957,000.00
  • ESQ $120,124,000.00
  • Revenue This Year
  • PCRX $5.14
  • ESQ N/A
  • Revenue Next Year
  • PCRX $2.44
  • ESQ $10.75
  • P/E Ratio
  • PCRX N/A
  • ESQ $16.70
  • Revenue Growth
  • PCRX 4.40
  • ESQ 10.21
  • 52 Week Low
  • PCRX $11.16
  • ESQ $44.45
  • 52 Week High
  • PCRX $31.67
  • ESQ $90.18
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • ESQ 59.14
  • Support Level
  • PCRX $25.06
  • ESQ $85.34
  • Resistance Level
  • PCRX $27.10
  • ESQ $90.18
  • Average True Range (ATR)
  • PCRX 1.45
  • ESQ 2.79
  • MACD
  • PCRX 0.28
  • ESQ 0.02
  • Stochastic Oscillator
  • PCRX 86.23
  • ESQ 71.79

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.

Share on Social Networks: